Condensed Consolidated Statements of Cash Flow - USD ($)	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net loss including non controlling interest	$ (99,859,078)	$ (14,201,151)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,185,858	1,624,208
Stock based compensation	56,303,135
Deferred income taxes	(86,020)	(131,378)
Unrealised foreign exchange loss/(profit)	(459,190)	9,184
Fair value losses in financial instruments carried at fair value	19,475,005	1,009,374
Gain on deconsolidation of subsidiaries	(2,098,745)
Gain on fair valuation of investments	(1,812)
Impairment of investment	3,395,234
Gain on sale of property and equipment		(625)
Expected credit loss (net of reversal)	293,853
Provision on doubtful advances and receivables	4,877,222
Lease equalisation reserve		(9,675)
Impairment loss		919,517
Balances written off/(back)	(51,513)	7,164
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:
Inventories	(11,688)	(9,352)
Income taxes, net	(64,243)	(55,766)
Accounts receivables, net	5,865,550	(943,470)
Prepayments and other assets	(23,861,458)	(529,692)
Accounts payable and accrued expenses and other current liabilities	19,344,448	4,193,439
Other liabilities	(674,090)	571,519
Net cash used in operating activities	(15,427,532)	(7,546,704)
Cash flows from investing activities
Purchase of property and equipment, intangible assets and goodwill	(455,924)	(842,045)
Proceeds from sale of property, plant and equipment		686
Acquisition of businesses	(5,749,200)
Investment in mutual funds	(500,000)
Net cash used in investing activities	(6,705,124)	(841,359)
Cash flows from financing activities
Proceeds from business combination	26,824
Proceeds from issue of preferred stock	6,079,409	458,000
Proceeds from exercise of preferred share warrants		9,996
Proceeds from long-term borrowings	2,438,014	4,107,029
Repayments of long-term borrowings	(11,684)	(612,645)
Net proceeds/(payments) from short-term borrowings	13,039,186	4,398,343
Net cash generated from financing activities	21,571,749	8,360,723
Effect of exchange rate changes on cash and cash equivalents	(244,444)	72,752
Net (decrease)/increase in cash and cash equivalents (including restricted cash)	(805,351)	45,412
Cash acquired in business combination	11,238,609
Cash and cash equivalents at the beginning of the period (including restricted cash)	1,131,830	1,086,418
Cash and cash equivalents at the end of the period (including restricted cash)	11,565,088	1,131,830
Reconciliation of cash and cash equivalents
Cash and cash equivalents	11,186,095	589,340
Restricted cash	378,993	542,490
Total cash and cash equivalents	11,565,088	1,131,830
Supplemental disclosure of cash flow information
Cash paid for interest, net of amounts capitalized	623,525	457,177
Cash paid for income taxes, net of refunds		141,228
Non-cash investing and financing activities
Exercise of warrant for issuance of convertible preferred stock		103,159
Convertible preferred stock issued on conversion of convertible notes		24,006,892
Consideration payable in connection with acquisitions	488,000	243,036
Interest accrued on borrowings	$ 451,323	$ 257,188